Press Releases

Tuesday 01/31/2012
AssureRx Health, Inc., today announced that it has secured an $8 million Term and Revolving Credit Facility that provides additional capital to support increasing clinical adoption of GeneSightRx and to finance multiple new products scheduled for...
Tuesday 01/24/2012
AssureRx Health, Inc., announced today that its laboratory has been certified by the New York State Department of Health, ensuring that patients throughout New York State have access to the GeneSightRx® testing program through their personal...
Tuesday 01/17/2012
The enhancements include the addition of six new psychotropic medications to the current panel of 26 medications, expanded support for mobile devices, and new capabilities to fast-track research discoveries into clinical practice.
Wednesday 10/12/2011
AssureRx Health, Inc., and the City of Mason, Ohio, today announced an agreement to locate its new company headquarters and dry laboratory at the Mason Community Center to accommodate the company’s employee growth and increasing demand for its...
Wednesday 09/07/2011
AssureRx Health, Inc., today announced three additions to its senior management team. These additions coincide with increasing adoption of GeneSightRx® pharmacogenetic testing aimed at assisting healthcare providers manage side effects and drug...
Thursday 05/12/2011
AssureRx Health, Inc., today announced two presentations on the clinical practice of utilizing its pharmacogenetic test, GeneSightRx®, at the 164th Annual Meeting of the American Psychiatric Association (APA) in Honolulu, May 14-18, 2011. Key...
Wednesday 05/11/2011
Program is Largest Commercial Pilot of AssureRx's GeneSightRx® Test to Help Physicians Select Appropriate Medications for Individual Patients with Neuropsychiatric Disorders
Friday 03/25/2011
Personalized Medicine Company to Expand Marketing and Product Development for Neuropsychiatric Pharmacogenetics
Monday 02/14/2011
AssureRx Health, Inc. today announced that it has expanded its laboratory-developed GeneSightRx® pharmacogenetic test with a sixth gene, CYP2C9, to further support clinicians in prescribing medications for behavioral health patients.
Tuesday 02/01/2011
AssureRx Health, Inc. today announced the appointments of two senior executives in key roles to drive company growth. Donald R. Wright, Jr. has been appointed as executive vice president & chief operating officer and John A. Bellano as senior vice...
Tuesday 09/28/2010
Treatment-Support Product Provides Objective, Easy-to-Use Information to Help Physicians Select Appropriate Medications for Individual Psychiatric Patients
Tuesday 08/10/2010
AssureRx Health Receives Accreditation from the College of American Pathologists (CAP) for the Delivery of High-Quality, Reliable Laboratory Pharmacogenetic Testing Services that Meet or Exceed Regulatory Laboratory Standards
1 | 2